ArticleBulletin of the World Health Organization2026
Medicines for treatment of older people in guidelines and essential medicines lists, WHO African Region.
Article in Bulletin of the World Health Organization, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multisectoral policy and health systems responses to ageing populations.Bulletin of the World Health Organization · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess the geriatric medicine content in national standard treatment guidelines and essential medicines lists across the 47 Member States of the World Health Organization (WHO) African Region. Methods: Until 28 June 2025, we searched for national guidelines and lists in the Global Essential Medicines database and the WHO Repository of National Essential Medicines Lists. We examined each document for a geriatric medicine chapter and guidance on the management of frailty, falls, palliative care, osteoporosis, parkinsonism, incontinence, delirium, dementia and polypharmacy. We obtained country-level data from the World Bank and WHO. Using Findings: We obtained a standard treatment guideline or essential medicines list from all 47 countries. Six (13%) documents contained a geriatric medicine chapter (five in English, one in French). Guidance on parkinsonism was the most common (42 documents; 89%), while guidance on frailty was the least common (three documents; 6%). Guidance on dementia was associated with current and predicted percentage population aged 65 years or older ( Conclusion: Countries in the African Region with a higher proportion of people older than 65 years were more likely to include geriatric medicine content in their standard treatment guidelines and essential medicines lists. There is considerable potential for expanding guidance on management of common geriatric conditions, such as frailty, incontinence and polypharmacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.